Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Link opens in a new tab
Search content at Tel Aviv University
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Antithymocyte globulin therapy in autoimmune diseases
G. Zandman-Goddart
*
,
P. Langevitz
,
Y. Shoenfeld
*
Corresponding author for this work
Sheba Medical Center at Tel Hashomer
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Antithymocyte globulin therapy in autoimmune diseases'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Autoimmune Disease
100%
Antithymocyte Globulin
100%
Fever
20%
Viral Infection
20%
Adverse Effects
20%
Bacterial Infection
20%
Regeneration
20%
Suppression Effect
20%
Rheumatoid Arthritis
20%
T Cells
20%
T Cell Subpopulations
20%
Skin Involvement
20%
Systemic Lupus Erythematosus
20%
Systemic Sclerosis
20%
Joint Involvement
20%
Pulmonary Fibrosis
20%
Autoimmune Hemolytic Anemia
20%
Alternative Therapy
20%
Prolonged Effect
20%
Glomerulonephritis
20%
Serum Sickness
20%
Refractory Autoimmune Disease
20%
Autoimmune Phenomena
20%
Immunology and Microbiology
Autoimmune Disease
100%
Anti-Thymocyte Globulin
100%
T Cell
40%
Inflammatory Arthritis
20%
Autoimmunity
20%
Cell Population
20%
Systemic Lupus Erythematosus
20%
Systemic Scleroderma
20%
Glomerulonephritis
20%
Autoimmune Hemolytic Anemia
20%
Serum Sickness
20%
Virus Infection
20%
Adverse Effect
20%